BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Nov 08, 2004
 |  BioCentury  |  Regulation

CMS spare change

CMS spare change

Drug Company Indication 2004 final 2005 proposed 2005 final 2004-05 % chg
Aranesp darbepoetin alfa Amgen Anemia $3.88 $4.14 $3.66 -6%
Enbrel etanercept Amgen Rheumatoid arthritis (RA), psoriatic arthritis, ankylosing spondylitis

Read the full 260 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >